Targeting targeted agents: open issues for clinical trial design

Molecularly targeted agents for the treatment of solid tumors had entered the market in the last 5 years, with a great impact upon both the scientific community and the society. Many randomized phase III trials conducted in recent years with new targeted agents, despite previous data coming from pre...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bria, Emilio, Di Maio, Massimo, Carlini, Paolo, Cuppone, Federica, Giannarelli, Diana, Cognetti, Francesco, Milella, Michele
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697149/
https://ncbi.nlm.nih.gov/pubmed/19463172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-66
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky